SynAct Surveys Its Options As Rheumatoid Arthritis Asset Succeeds At Phase II

Partnership Or Acquisition On The Cards

 
• By Ayisha Sharma
  
Rheumatoid Arthritis Affects Up To 1% Of The Global Population • Source: Alamy

More from Clinical Trials

More from R&D